ExploreWatchlistsPricing
  1. JP-listed companies
  2. Linical Co., Ltd.
  3. Financials
  4. Total liabilities

Linical Co., Ltd. (2183)

Market cap
¥5.2B
P/E ratio
26.2x
Linical helps pharmaceutical companies develop and launch new drugs by providing clinical trial services, post-market safety monitoring, and drug discovery support.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
Mar 31, 20268,023-15.74%
Mar 31, 20259,522-7.60%
Mar 31, 202410,305+4.26%
Mar 31, 20239,883+7.74%
Mar 31, 20229,173-4.13%
Mar 31, 20219,568+7.24%
Mar 31, 20208,922+11.41%
Mar 31, 20198,008+98.09%
Mar 31, 20184,043-3.83%
Mar 31, 20174,204+2.40%
Mar 31, 20164,105+14.62%
Mar 31, 20153,582

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat